Vyvgart brought us back to life (Mia)
- Condition
- Long COVID
- At worst
- Moderate (mostly housebound)
- Ill for
- Not stated
- Published
- Oct 2025
Summary
Mia Delli Gatti took part in the same Vyvgart (efgartigimod) trial, though the article gives no specific dose or schedule for her. As a college student, Long COVID had previously left her unable to maintain a full course load, but on the drug she was able to take a full course load while also holding a job. The article does not describe what happened to her after the trial ended, so it is unclear whether this improvement held or faded.
What they credit
Credits Biologics & antibodies, Trauma & somatic work, Efgartigimod / Vyvgart.
Similar stories
-
Vyvgart brought us back to life (Clare)
Clare, a nurse previously unable to work because of Long COVID, received Vyvgart (efgartigimod) in the trial, with no specific dose stated, and it significantly improved her tachycardia and lessened her post-exertional malaise. After the trial ended, her…
-
Vyvgart brought us back to life (Michaelene)
Michaelene was on Vyvgart (efgartigimod) for five months in the trial's open-label phase and had improved enough that she no longer met criteria for POTS when the trial was abruptly canceled. She had been severely disabled before treatment. After the trial…
-
Vyvgart brought us back to life (Ellie)
Ellie also received Vyvgart (efgartigimod) in the trial, with no specific dose described. A geologist previously limited by severe Long COVID symptoms, she improved enough on the drug to resume field work without fearing she would pass out. The article does…
-
Vyvgart brought us back to life (Nicole)
Nicole Barrick, a nurse who contracted COVID while working on a COVID unit, received weekly Vyvgart (efgartigimod) infusions, and after six months in the trial's open-label phase she no longer met the clinical criteria for POTS on tilt-table testing, with…